Last updated on September 2018

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

Brief description of study

To assess the safety and efficacy of REGN2810 as first-line treatment in patients with advanced or metastatic NSCLC whose tumors express PD-L1.

Detailed Study Description

There is option to join genomics sub-study.

Clinical Study Identifier: NCT03088540

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Administrator

Clinical Study Site
Batumi, Georgia
  Connect »